Drugs targeting amyloid plaques have failed to show efficacy in clinical trials. A new approach is needed to tackle AD ...

The nucleus accumbens ... from the D1 receptor, which cells co-express with D3 receptors." Whole-brain imaging of D3-MSN projections. This video shows tdTomato-labeled fibers and Syn-GFP-labeled ...

It’s not enough to simply call Bob Uecker an original, "1 of 1" or the last of his kind. Uecker was both the OG and the ...

While the last decade has brought considerable progress for patients with DMD, substantial unmet need remains. Several ...

They also labeled where each cell had been taken from in the brain ... Here we collected paired single-nucleus chromatin accessibility and transcriptome data from 38 human neocortical samples ...

A team of researchers at Åbo Akademi University in Finland made a surprising discovery. They found that Talin-1, a protein ...

Mysterious Blobs Found inside Cells Are Rewriting the Story of How Life Works Tiny specks called biomolecular condensates are ...

Human immunodeficiency virus type 1 (HIV-1) targets important cells of our immune system, making infected individuals more ...

The company, founded by 25-year-old Kian Sadeghi, announced a $14 million Series A, bringing its total funding to about $32 million.

AlleyWatch sat down with Nucleus CEO and Founder Kian Sadeghi to learn more about the business, its future plans, and recent ...